يعرض 1 - 20 نتائج من 80 نتيجة بحث عن '"Furman, RR"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    Relation: Byrd, J. C., Hillmen, P., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., O'Brien, S., Yenerel, M. N., Illes, A., Kay, N., Garcia-Marco, J. A., Mato, A., Pinilla-Ibarz, J., Seymour, J. F., Lepretre, S., Stilgenbauer, S., Robak, T., Rothbaum, W., Izumi, R. ,. Jurczak, W. (2021). Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial. JOURNAL OF CLINICAL ONCOLOGY, 39 (31), pp.3441-+. https://doi.org/10.1200/JCO.21.01210.; http://hdl.handle.net/11343/289520

  10. 10
    Academic Journal

    المساهمون: Arruga F, Bracciamà V, Vitale N, Vaisitti T, Gizzi K, Yeomans A, Coscia M, D'Arena G, Gaidano G, Allan JN, Furman RR, Packham G, Forconi F, Deaglio S

    Relation: info:eu-repo/semantics/altIdentifier/pmid/31467429; info:eu-repo/semantics/altIdentifier/wos/WOS:000523481800014; firstpage:1; lastpage:12; numberofpages:12; journal:LEUKEMIA; http://hdl.handle.net/2318/1711579; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85071917960

  11. 11
    Academic Journal
  12. 12
    Academic Journal

    Relation: Jones, J., Mato, A., Coutre, S., Byrd, J. C., Furman, R. R., Hillmen, P., Osterborg, A., Tam, C., Stilgenbauer, S., Wierda, W. G., Heerema, N. A., Eckert, K., Clow, F., Zhou, C., Chu, A. D., James, D. F. & O'Brien, S. M. (2018). Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocyticleukaemia treated with ibrutinib from 3 clinical trials. BRITISH JOURNAL OF HAEMATOLOGY, 182 (4), pp.504-512. https://doi.org/10.1111/bjh.15421.; http://hdl.handle.net/11343/271068

  13. 13
    Academic Journal
  14. 14
    Academic Journal

    Relation: Jones, J. A., Hillmen, P., Coutre, S., Tam, C., Furman, R. R., Barr, P. M., Schuster, S. J., Kipps, T. J., Flinn, I. W., Jaeger, U., Burger, J. A., Cheng, M., Ninomoto, J., James, D. F., Byrd, J. C. & O'Brien, S. M. (2017). Use of anticoagulants and antiplatelet in patients with chronic lymphocytic leukaemia treated with single-agent ibrutinib. BRITISH JOURNAL OF HAEMATOLOGY, 178 (2), pp.286-291. https://doi.org/10.1111/bjh.14660.; http://hdl.handle.net/11343/259160

  15. 15
    Conference

    المساهمون: Arruga, F, Bracciama, V, Yeomans, A, D'Avola, A, Coscia, M, D'Arena, GF, Gaidano, G, Allan, JN, Furman, RR, Packham, G, Deaglio, S, Forconi, F

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000454837605187; 60th Annual Meeting of the American-Society-of-Hematology (ASH); volume:132; issue:Supplement 1; firstpage:1832; lastpage:1832; numberofpages:1; journal:BLOOD; http://hdl.handle.net/2318/1807153

  16. 16
    Academic Journal

    Relation: Ghia, P, Coutre, SE, Cheson, BD et al. (7 more authors) (2020) Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase 3 randomized trial. Haematologica. ISSN 0390-6078

  17. 17
    Conference

    المساهمون: Arruga, F, Gizdic, B, Bologna, C, Cignetto, S, Buonincontri, R, Serra, S, Vaisitti, T, Vitale, N, Garaffo, G, Mereu, E, Diop, F, Neri, F, Coscia, M, Allan, JN, Piva, R, Oliviero, S, Furman, RR, Rossi, D, Gaidano, G, Deaglio, S

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000394446805047; 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); volume:128; issue:22; firstpage:969; lastpage:969; numberofpages:1; journal:BLOOD; http://hdl.handle.net/2318/1691085

  18. 18
    Academic Journal

    Relation: Wierda, W. G., Byrd, J. C., O'Brien, S., Coutre, S., Barr, P. M., Furman, R. R., Kipps, T. J., Burger, J. A., Stevens, D. A., Sharman, J., Ghia, P., Flinn, I. W., Zhou, C., Ninomoto, J., James, D. F. & Tam, C. S. (2019). Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY, 186 (1), pp.184-188. https://doi.org/10.1111/bjh.15791.; http://hdl.handle.net/11343/285432

  19. 19
  20. 20
    Conference

    المساهمون: Serra, S, Brusa, D, Vaisitti, T, Buonincontri, R, Audrito, V, Coscia, M, Rossi, D, Bhavsar, Eb, Furman, Rr, Gaidano, G, Deaglio, S

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000368021801087; 57th Annual Meeting of the American-Society-of-Hematology; volume:126; issue:23; firstpage:4145; lastpage:4145; numberofpages:1; journal:BLOOD; http://hdl.handle.net/2318/1617729